Home › Funds › BECK MACK & OLIVER LLC › FTRE
BECK MACK & OLIVER LLC position in FTRE
FORTREA HOLDINGS · Health Care
BECK MACK & OLIVER LLC reported holding 834,758 shares of FTRE (FORTREA HOLDINGS) in its Q2 2026 13F filing — a position valued at US$14.5M, representing 0.31% of its reported portfolio and ranking #46 among its reported holdings. BECK MACK & OLIVER LLC has disclosed FTRE holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How BECK MACK & OLIVER LLC's FTRE position evolved
BECK MACK & OLIVER LLC first disclosed a stake in FTRE in Q3 2023 at 2,031,423 shares (US$58.1M). The position peaked in Q3 2024 at 5,853,399 shares, worth US$117.1M. Across 12 filings, BECK MACK & OLIVER LLC increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 834,758 shares valued at US$14.5M — a reduction of -112,990 shares quarter over quarter.. Notable position changes include a 49% increase in Q2 2024 (shares fell 14% over the following quarter), a 65% increase in Q3 2024 (shares fell 7% over the following quarter), a 48% trim in Q1 2025 (shares fell 35% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.03M | $58.08M | New |
| Q4 2023 | 2.13M | $74.33M | Add |
| Q1 2024 | 2.37M | $95.06M | Add |
| Q2 2024 | 3.54M | $82.55M | Add |
| Q3 2024 | 5.85M | $117.07M | Add |
| Q4 2024 | 5.64M | $105.11M | Reduce |
| Q1 2025 | 2.94M | $22.16M | Reduce |
| Q2 2025 | 2.02M | $9.97M | Reduce |
| Q3 2025 | 1.40M | $11.82M | Reduce |
| Q4 2025 | 804.65K | $13.88M | Reduce |
| Q1 2026 | 947.75K | $8.93M | Add |
| Q2 2026 | 834.76K | $14.52M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About FTRE and 13F data
FTRE (FORTREA HOLDINGS) is a Health Care company. 36 other funds we track also report a position in FTRE — the largest reported positions include Sessa Capital IM, L.P. (US$79.9M), Corvex Management (US$52.0M), Park West Asset Management LLC (US$36.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding FTRE
- Sessa Capital IM, L.P. 4.59M sh · $79.93M · Q2 2026
- Corvex Management 2.99M sh · $52.00M · Q2 2026
- Park West Asset Management LLC 2.11M sh · $36.65M · Q2 2026
- Eagle Health Investments LP 1.18M sh · $20.55M · Q2 2026
More on BECK MACK & OLIVER LLC
FAQ
How long has BECK MACK & OLIVER LLC held FTRE?
BECK MACK & OLIVER LLC has disclosed FTRE holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is BECK MACK & OLIVER LLC's current position in FTRE?
As of Q2 2026, BECK MACK & OLIVER LLC holds 834.76K shares of FTRE (FORTREA HOLDINGS), valued at $14.52M, representing 0.31% of its reported portfolio and ranking #46.
Has BECK MACK & OLIVER LLC been buying or selling FTRE?
In the latest 13F filing (Q2 2026), BECK MACK & OLIVER LLC reduced its position in FTRE. The position peaked in Q3 2024 at 5.85M shares.
Which other funds hold FTRE?
Other major institutional holders of FTRE include Sessa Capital IM, L.P., Corvex Management, Park West Asset Management LLC, among 36 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.